OFFICIAL PUBLICATION OF

by its subsidiary APPco

Price reduction for combinations

Chris Brooker 02/08/2016

A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures.The newly advised cuts will affect combination drugs due to experience flow-on price reductions.The 2015 Access and Sustainability amendments to the National Health Act 1953 provide for price disclosure reductions to component drugs to be flowed-on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Transaction fees drive MedAdvisor growth

An 89% gross margin? Wow. That's just staggering considering the lack of service and reliability.

Marion Crowther

Transaction fees drive MedAdvisor growth

Why are other software providers - like Z-software not able to introduce a competing system ? Monopolies breed inefficiency.

Robert Smith

Wholesaling deal needs ‘radical restructure’ in 8CPA

Does the Remote and Isolated Pharmacist Association Australia have a website, or contact information?

D vL

Monopolists a threat to small business

This is a reproduced article form the AJP in 1949 - as stated in the introduction. AJP regularly reproduces articles…

(Mary) Kay Dunkley

Price reduction for combinations

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Clinical tips: Timing!

Clinical tips: Movement disorders

Clinical tips: Worms, Worms, Worms

Intranasal Midazolam for at home use

MENU

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.